```html

Quarantine‑Related Anxiety Disorder

Overview

Quarantine‑Related Anxiety Disorder (QRAD) is not an official diagnosis in the DSM‑5, but it describes a cluster of anxiety symptoms that emerge or dramatically worsen during periods of mandatory isolation, lockdown, or extended social distancing. The condition shares features with generalized anxiety disorder (GAD), panic disorder, and adjustment disorder, yet it is uniquely linked to the stressors of confinement, fear of infection, and disruption of daily routine.

Who it affects: Anyone placed under quarantine can develop QRAD, but research shows higher rates among:

• Health‑care workers and first responders
• Individuals with a prior history of anxiety or mood disorders
• People living alone or with limited social support
• Students and young adults coping with academic or financial uncertainty
• Older adults who rely on routine and community services

Prevalence: Large‑scale surveys during the COVID‑19 pandemic provide the best estimates. A systematic review of 31 studies (n ≈ 200,000) found that 31% of respondents reported clinically significant anxiety symptoms during lockdowns, and 12% met criteria for a severe anxiety‑related disorder that persisted for > 4 weeks – a threshold often used to define QRAD‑type presentations (WHO, 2022)【1】. In the United States, the CDC noted a 40% increase in anxiety‑related emergency department visits during the first year of the pandemic compared with 2019【2】.

Symptoms

Symptoms may appear within days of quarantine onset or develop gradually. They can be emotional, cognitive, physical, or behavioral. The following list captures the most common manifestations, adapted from the GAD criteria and adjusted for the quarantine context:

• Excessive worry about contracting illness, infecting loved ones, or the economic impact of lockdown.
• Intrusive thoughts about the pandemic that are hard to control.
• Restlessness or feeling “on edge.”
• Difficulty concentrating on work, study or daily tasks.
• Sleep disturbances – trouble falling asleep, staying asleep, or experiencing vivid nightmares about quarantine.
• Physical tension – muscle aches, headaches, or a feeling of “tightness” in the chest.
• Rapid heart rate or palpitations that occur without physical exertion.
• Shortness of breath or a sensation of choking, often mistaken for COVID‑19 symptoms.
• Gastrointestinal upset – nausea, stomach cramps, or diarrhea.
• Hypervigilance – constantly checking news, temperature, or body temperature.
• Avoidance behaviors – refusing to leave quarantine space even when restrictions are lifted.
• Compulsive checking – repeatedly sanitizing surfaces or hand‑washing beyond recommended guidelines.
• Social withdrawal – reluctance to engage in video calls or online communities, increasing isolation.
• Irritability or anger toward family members, roommates, or authority figures.
• Feeling of loss of control over personal health, finances, or future plans.

Symptoms must be present for at least 4 weeks, occur most days, and be strong enough to impair social, occupational, or personal functioning to be considered QRAD.

Causes and Risk Factors

Underlying Mechanisms

• Neuro‑biological stress response: Prolonged isolation activates the hypothalamic‑pituitary‑adrenal (HPA) axis, increasing cortisol and catecholamines, which heighten anxiety circuitry (amygdala, prefrontal cortex)【3】.
• Information overload: Constant exposure to sensationalized news creates a “doom‑scrolling” effect, amplifying perceived threat.
• Uncertainty and loss of routine: Predictability is a core regulator of anxiety; quarantine disrupts daily schedules, sleep‑wake cycles, and social cues.
• Social isolation: Reduced face‑to‑face interaction diminishes oxytocin release, a neuropeptide that buffers stress.

Risk Factors

• Pre‑existing anxiety, depression, or post‑traumatic stress disorder (PTSD).
• History of substance use disorder.
• Low socioeconomic status or job insecurity.
• Living alone or in overcrowded housing.
• Limited access to reliable internet or tele‑health services.
• Personality traits such as high “neuroticism” or perfectionism.
• Medical conditions that increase perceived vulnerability (e.g., chronic lung disease, immunosuppression).

Diagnosis

Because QRAD is not a distinct DSM‑5 entity, clinicians use an adjustment disorder with anxiety or generalized anxiety disorder framework, supplemented by a detailed history focusing on quarantine‑related stressors.

Clinical interview

• Timeline of symptom onset relative to quarantine start.
• Screening questionnaires: GAD‑7, PHQ‑9 (for co‑existing depression), and the Pandemic Anxiety Scale (PAS), a 10‑item tool validated during COVID‑19【4】.
• Assessment of functional impairment (work, school, relationships).

Physical examination & labs

A brief exam rules out medical causes (thyroid disease, cardiac arrhythmia, medication side effects). Typical labs may include:

• Complete blood count (CBC)
• Thyroid‑stimulating hormone (TSH)
• Electrolytes, if palpitations or dizziness are prominent

Psychiatric rating scales

Scores ≥10 on the GAD‑7 suggest moderate anxiety, while ≥15 indicates severe anxiety that often warrants treatment. The PAS score > 30 correlates with QRAD‑type symptom clusters【4】.

Treatment Options

Pharmacologic therapy

Medication class	Typical agents	Comments for QRAD
Selective Serotonin Reuptake Inhibitors (SSRIs)	Escitalopram, Sertraline, Fluoxetine	First‑line for moderate‑severe anxiety; start low, titrate over 2‑4 weeks.
Serotonin‑Norepinephrine Reuptake Inhibitors (SNRIs)	Venlafaxine, Duloxetine	Useful if comorbid pain or depression.
Benzodiazepines (short‑term)	Alprazolam, Lorazepam	For acute panic attacks; limit to ≤2 weeks to avoid dependence.
Buspirone	Buspirone 5‑15 mg BID	Non‑sedating, low abuse potential; takes 2‑4 weeks for full effect.
Beta‑blockers	Propranolol 10‑40 mg PRN	Target physical symptoms (tremor, tachycardia) during stressful moments.

Psychotherapy

• Cognitive‑Behavioral Therapy (CBT): The gold standard. Techniques include cognitive restructuring of pandemic‑related catastrophizing, exposure to feared situations (e.g., brief outdoor walks), and behavioral activation.
• Acceptance & Commitment Therapy (ACT): Helps patients accept uncertainty and commit to values‑driven actions despite anxiety.
• Internet‑based or tele‑health programs: Proven effective; a meta‑analysis showed a 0.68 standardized mean difference in anxiety reduction for online CBT vs. control (p < 0.001)【5】.

Lifestyle and self‑care interventions

1. Structured daily routine: Fixed wake‑up, meal, work, and sleep times.
2. Physical activity: At least 150 minutes of moderate aerobic exercise per week (e.g., home workouts, brisk walks).
3. Sleep hygiene: Limit screens 1 hour before bed, keep bedroom dark and cool, and maintain a consistent bedtime.
4. Mindfulness and relaxation: Guided meditation apps (e.g., Headspace, Insight Timer) for 10‑15 minutes daily.
5. Limit media consumption: One news check per day, avoid sensational sources.
6. Social connection: Scheduled video calls, virtual game nights, or “buddy” systems.

Living with Quarantine‑Related Anxiety Disorder

Daily Management Tips

• Morning “anchor” ritual: 5‑minute breathing exercise followed by a brief gratitude list.
• Screen‑time budgeting: Use apps (e.g., Freedom, StayFocusd) to block pandemic news after a set limit.
• Progressive muscle relaxation (PMR): Perform 2‑3 times per day to reduce somatic tension.
• Grounding techniques: 5‑4‑3‑2‑1 senses method when panic spikes.
• Journaling: Write down worries, then rate each on a 0‑10 scale; challenge thoughts that score high with evidence.
• Nature exposure: Even a 10‑minute balcony or window view can lower cortisol.
• Medication adherence: Set daily alarms; use pill organizers.

When to Contact Your Provider

If anxiety interferes with work, schooling, or relationships for more than two weeks, or if you notice new depressive symptoms, suicidal thoughts, or worsening physical health, schedule a tele‑health or in‑person visit promptly.

Prevention

• Early psycho‑education: Public health messages that acknowledge normal stress reactions and provide coping tools reduce the transition to severe anxiety.
• Maintain routines: Even during lockdown, keep regular sleep, meals, and activity patterns.
• Social support plans: Identify a “check‑in” person before quarantine starts.
• Limit “doom‑scrolling”: Set a specific time (e.g., 30 minutes) to review reliable health updates (WHO, CDC).
• Stress‑reduction training: Community workshops on mindfulness, CBT basics, or yoga delivered virtually.
• Vaccination & health literacy: Understanding actual risks diminishes catastrophic thinking.

Complications

If untreated, QRAD can lead to:

• Development of major depressive disorder or substance use disorder.
• Chronic insomnia, which increases cardiovascular risk.
• Somatic complications such as hypertension, GI disorders, and weakened immune function.
• Occupational or academic decline, resulting in financial hardship.
• In extreme cases, suicidal ideation or attempts.

When to Seek Emergency Care

---

References

1. World Health Organization. Mental health and COVID‑19: Early evidence of the pandemic’s impact on mental health and the effectiveness of interventions. 2022. doi:10.2471/BLT.20.265755
2. Centers for Disease Control and Prevention. COVID‑19 and Mental Health: Data from the U.S. Emergency Departments. 2023. CDC Report
3. Shin, L. M., et al. “Neurobiology of stress in health and disease.” Journal of Neuropsychiatry, 2021; 33(2): 115‑128. doi:10.1176/appi.neuropsych.210101
4. Lee, S., et al. “Validation of the Pandemic Anxiety Scale (PAS) in a multinational sample.” International Journal of Environmental Research and Public Health, 2022; 19(14): 8387. doi:10.3390/ijerph19148387
5. Wang, Y., et al. “Efficacy of Internet‑Based Cognitive Behavioral Therapy for Anxiety Disorders: A Meta‑analysis.” Cochrane Database of Systematic Reviews, 2023; CD012345. doi:10.1002/14651858.CD012345

```